16-4337423-A-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_032575.3(GLIS2):āc.1474A>Gā(p.Thr492Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0398 in 1,584,644 control chromosomes in the GnomAD database, including 1,809 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. T492T) has been classified as Likely benign.
Frequency
Consequence
NM_032575.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLIS2 | NM_032575.3 | c.1474A>G | p.Thr492Ala | missense_variant | 7/7 | ENST00000433375.2 | NP_115964.2 | |
GLIS2 | NM_001318918.2 | c.1474A>G | p.Thr492Ala | missense_variant | 8/8 | NP_001305847.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLIS2 | ENST00000433375.2 | c.1474A>G | p.Thr492Ala | missense_variant | 7/7 | 1 | NM_032575.3 | ENSP00000395547 | P1 | |
ENST00000574705.1 | n.396T>C | non_coding_transcript_exon_variant | 1/1 | |||||||
GLIS2 | ENST00000262366.7 | c.1474A>G | p.Thr492Ala | missense_variant | 8/8 | 2 | ENSP00000262366 | P1 | ||
PAM16 | ENST00000577031.5 | c.291+3497T>C | intron_variant | 4 | ENSP00000459113 |
Frequencies
GnomAD3 genomes AF: 0.0615 AC: 9351AN: 152026Hom.: 433 Cov.: 33
GnomAD3 exomes AF: 0.0335 AC: 6581AN: 196554Hom.: 177 AF XY: 0.0315 AC XY: 3379AN XY: 107412
GnomAD4 exome AF: 0.0374 AC: 53622AN: 1432500Hom.: 1372 Cov.: 34 AF XY: 0.0364 AC XY: 25866AN XY: 710542
GnomAD4 genome AF: 0.0617 AC: 9386AN: 152144Hom.: 437 Cov.: 33 AF XY: 0.0598 AC XY: 4451AN XY: 74394
ClinVar
Submissions by phenotype
not specified Benign:2
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 03, 2014 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jul 14, 2018 | - - |
Nephronophthisis Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Nephronophthisis 7 Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at